[go: up one dir, main page]

GB201507723D0 - Anti-bacterial agents and their use in therapy - Google Patents

Anti-bacterial agents and their use in therapy

Info

Publication number
GB201507723D0
GB201507723D0 GBGB1507723.3A GB201507723A GB201507723D0 GB 201507723 D0 GB201507723 D0 GB 201507723D0 GB 201507723 A GB201507723 A GB 201507723A GB 201507723 D0 GB201507723 D0 GB 201507723D0
Authority
GB
United Kingdom
Prior art keywords
therapy
bacterial agents
bacterial
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1507723.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norwegian University of Science and Technology NTNU
Original Assignee
Norwegian University of Science and Technology NTNU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwegian University of Science and Technology NTNU filed Critical Norwegian University of Science and Technology NTNU
Priority to GBGB1507723.3A priority Critical patent/GB201507723D0/en
Publication of GB201507723D0 publication Critical patent/GB201507723D0/en
Priority to PCT/EP2016/060233 priority patent/WO2016177900A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0029—Radiation
    • A61L2/0047—Ultraviolet radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0624—Apparatus adapted for a specific treatment for eliminating microbes, germs, bacteria on or in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Radiology & Medical Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Marine Sciences & Fisheries (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1507723.3A 2015-05-06 2015-05-06 Anti-bacterial agents and their use in therapy Ceased GB201507723D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1507723.3A GB201507723D0 (en) 2015-05-06 2015-05-06 Anti-bacterial agents and their use in therapy
PCT/EP2016/060233 WO2016177900A1 (en) 2015-05-06 2016-05-06 Anti-bacterial agents and their use in therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1507723.3A GB201507723D0 (en) 2015-05-06 2015-05-06 Anti-bacterial agents and their use in therapy

Publications (1)

Publication Number Publication Date
GB201507723D0 true GB201507723D0 (en) 2015-06-17

Family

ID=53489190

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1507723.3A Ceased GB201507723D0 (en) 2015-05-06 2015-05-06 Anti-bacterial agents and their use in therapy

Country Status (2)

Country Link
GB (1) GB201507723D0 (en)
WO (1) WO2016177900A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12083158B2 (en) 2011-10-07 2024-09-10 Morehouse School Of Medicine Antibacterial compositions, methods of making and use thereof
WO2018197926A1 (en) * 2017-04-26 2018-11-01 Robert Penchovsky Methods for creating novel antibacterial agents using chimeric antisense oligonucleotides
CN108976288B (en) * 2017-06-05 2021-09-21 复旦大学 Lipophilic derivatives based on wild-type membrane-penetrating peptide penetratin
WO2019231848A1 (en) * 2018-05-30 2019-12-05 Morehouse School Of Medicine Antibacterial compositions, methods of making and use thereof
RU2688231C1 (en) * 2019-02-19 2019-05-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский государственный медицинский университет имени академика Е.А. Вагнера" Министерства здравоохранения Российской Федерации Method of treating leptopothia in the oral cavity
EP4554553A1 (en) * 2022-07-13 2025-05-21 L'oreal Modified peptides, composition, method for inhibiting contraction of muscle cells, method for improving the skin and use of a modified peptide
CN121079099A (en) * 2023-04-26 2025-12-05 深圳信立泰药业股份有限公司 PSD-95 structural domain inhibitor, preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4139863B2 (en) * 1993-03-12 2008-08-27 ゾーマ テクノロジー リミテッド Biologically active peptides derived from functional domains of proteins with improved bactericidal / permeability and uses thereof
AR083533A1 (en) * 2010-10-22 2013-03-06 Boehringer Ingelheim Vetmed PROTEINS OF HEMAGLUTININ 5 (H5) FOR THE TREATMENT AND PREVENTION OF INFLECTIONS OF FLU
GB201319621D0 (en) * 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Antimicrobial agents and their use in therapy

Also Published As

Publication number Publication date
WO2016177900A1 (en) 2016-11-10

Similar Documents

Publication Publication Date Title
ZA201904695B (en) Amino-triazolopyridine compounds and their use in treating cancer
IL255577B (en) Tigit-binding agents and uses thereof
IL253433A0 (en) Tnfrsf-binding agents and uses thereof
GB201319621D0 (en) Antimicrobial agents and their use in therapy
IL264813B (en) 2-oxo-imidazopyridines and their use
PL3256218T3 (en) A kdm1a inhibitor and its use in therapy
GB201511382D0 (en) Novel compounds and their use in therapy
PT3065759T (en) Immunosuppressive agents and their use in therapy
GB201507721D0 (en) Immunosuppressive agents and their use in therapy
GB201507722D0 (en) Anti-bacterial agents and their use in therapy
GB201507723D0 (en) Anti-bacterial agents and their use in therapy
GB201604213D0 (en) Drug combination and its use in therapy
GB201514021D0 (en) Novel Pyridines and their use in the treatment of cancer
IL248424B (en) Neuro-protective agents and uses thereof
EP3302530A4 (en) Cdh26 based therapeutic agents and their use
IL261648A (en) Cinnolin-4-amine compounds and their use in treating cancer
PL3129057T3 (en) Glycolipids and pharmaceutical compositions thereof for use in therapy
IL259358A (en) Bis-pyridazine compounds and their use in treating cancer
GB201418809D0 (en) Therapeutic agents and uses thereof
PT3325478T (en) New therapeutic compound and use in therapy
GB201615844D0 (en) Agents for use in therapy
PL3341481T3 (en) Microrna-328 anti-sense composition and therapeutic use
PL3106172T3 (en) Antimicrobial agents and their use
GB201409978D0 (en) Novel compounds and their use in therapy
GB201510764D0 (en) bis-Pyridazine compounds and their use in treating cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)